Pérez de Lema, Guillermo and Lucio-Cazaña, Francisco Javier and Molina, Ana and Luckow, Bruno and Schmid, Holger and de Wit, Cor and Moreno-Manzano, Victoria and Banas, Bernhard and Mampaso, Francisco and Schlöndorff, Detlef (2004) Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney international 66 (3), pp. 1018-1028.
Download (244kB) - Repository staff only
BACKGROUND: Retinoic acid (tRA) is an active metabolite of vitamin A with potent anti-inflammatory properties. We analyzed the effects of tRA on the development of lupus nephritis in MRL/lpr mice. METHODS: MRL/lpr mice received chow supplemented with vehicle or tRA (daily 10 mg/kg) from 8 to 14 weeks until their sacrifice. MRL/wt mice served as an additional control. RESULTS: tRA-treated MRL/lpr ...
Export bibliographical data
|Institutions:||Medicine > Lehrstuhl für Innere Medizin II|
|Subjects:||600 Technology > 610 Medical sciences Medicine|
|Refereed:||Yes, this version has been refereed|
|Created at the University of Regensburg:||Yes|
|Deposited On:||15 Mar 2007|
|Last Modified:||13 Mar 2014 09:49|